The Billion-Dollar Gamble: Confronting the Unforgiving Realities of Pharma R&D In the world of biopharmaceutical research and development, we operate […]

Executive Summary The global pharmaceutical industry is currently navigating a period of unprecedented structural transformation. We are standing on the

In pharmaceuticals 503B outsourcing facilities occupy a unique and often contentious space. Born from the ashes of a public health

On one hand, the pharmaceutical sector is driven by a scientific and economic imperative that thrives on openness: the seamless

Pharma IP teams, hedge funds, and biosimilar developers treat a Paragraph IV filing as a legal event. It is not.

Introduction: Beyond Serendipity – The New Strategic Imperative For decades, the pharmaceutical industry has operated on a model of heroic,

The Russian pharmaceutical market generated 2.85 trillion roubles in 2024 — but every dollar of that growth evaporated in currency

The Commonwealth of Independent States pharmaceutical market is one of the last large generic drug markets where the rules are

Brazil’s pharmaceutical sector has quietly become one of the most strategically interesting IP battlegrounds in the world. The country’s market